DIH Holding US, Inc.

DHAI

Healthcare Medical Devices

DIH Holding US, Inc.’s revenue for fiscal 2025 (year ended March 2025) was $62.9 million, down 2.50% from fiscal 2024.

Revenue
−30.7%
EPS
+43.1%
Free cash flow
−167.9%

Quarter to March 2025, against a year earlier

0.00 0.00 NaN
Market cap
$1.6M
P/E
n/m
Fwd P/E
—
Dividend yield
—
F-score
4/9
ROIC
0.00%
Net debt / EBITDA
−1.5×
Dividend safety
n/a
Older periods Jun '24 Sep '24 Dec '24 Mar '25
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
1.52 0.98 0.69 0.14
P/FCF ratio
19.91 23.71 12.93 0.00
P/Operating CF
(46.58) 137.89 69.69 (2.76)
P/B ratio
0.00 0.00 0.00 0.00
EV/Sales
1.69 1.14 0.84 0.29
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
22.16 27.42 15.67 (3.89)
Current Ratio
0.61 0.60 0.51 0.49
Net Debt/EBITDA
(6.79) 4.78 (4.08) (2.13)
Debt/Equity
(0.39) (0.36) (0.30) (0.30)
Earnings Yield
(15.57%) (16.43%) (23.39%) (102.88%)
Free Cash Flow Yield
5.02% 4.22% 7.73% (51.53%)
Free Cash Flow per Share
(1.62) 0.21 0.48 (2.16)
Book value per Share
(24.60) (24.89) (27.34) (23.63)
Free Cash Flow
(2.24) 0.29 0.67 (3.39)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026